Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Research & Development (2016 - 2025)

Axogen (AXGN) has 16 years of Research & Development data on record, last reported at $12.4 million in Q4 2025.

  • For Q4 2025, Research & Development rose 84.58% year-over-year to $12.4 million; the TTM value through Dec 2025 reached $32.9 million, up 18.43%, while the annual FY2025 figure was $32.9 million, 18.43% up from the prior year.
  • Research & Development reached $12.4 million in Q4 2025 per AXGN's latest filing, up from $7.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $12.4 million in Q4 2025 and bottomed at $5.7 million in Q2 2021.
  • Average Research & Development over 5 years is $7.0 million, with a median of $6.8 million recorded in 2022.
  • The widest YoY moves for Research & Development: up 84.58% in 2025, down 17.79% in 2025.
  • A 5-year view of Research & Development shows it stood at $6.3 million in 2021, then rose by 8.08% to $6.8 million in 2022, then grew by 5.34% to $7.2 million in 2023, then decreased by 6.55% to $6.7 million in 2024, then soared by 84.58% to $12.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $12.4 million in Q4 2025, $7.6 million in Q3 2025, and $6.9 million in Q2 2025.